Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rita Morigi is active.

Publication


Featured researches published by Rita Morigi.


European Journal of Medicinal Chemistry | 2001

Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles

Aldo Andreani; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi

A number of selected imidazo[2,1-b]thiazoles entered the screening at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) and one of these compounds, 2-chloro-6-phenylimidazo[2,1-b]thiazole, showed antitubercular activity. On this basis we planned the synthesis of new analogues bearing a substituted ring at the 6 position. For one compound only (2-chloro-6-p-chlorophenylimidazo[2,1-b]thiazole) the 5-nitroso derivative was also prepared. The antitubercular activity of these compounds was compared with the known analogues lacking the chlorine at the 2 position. 5-Nitroso-6-p-chlorophenylimidazo[2,1-b]thiazole showed potent antitubercular activity.


European Journal of Medicinal Chemistry | 1997

Synthesis and potential coanthracyclinic activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones†

Aldo Andreani; Alessandra Locatelli; Alberto Leoni; Mirella Rambaldi; Rita Morigi; Rosaria Bossa; M Chiericozzi; Alessandra Fraccari; I. Galatulas

Summary A compound endowed with coanthracyclinic activity should potentiate the antitumor activity of anthracyclines while counteracting their cardiodepressant effect. We now report the synthesis and configuration of a series of substituted 3-(5-imidazo[2,1- b ]thiazolylmethylene)-2-indolinones which were tested for both cardiotonic and cytotoxic activity. Several compounds were potent cytotoxic agents and two of them (in particular 3-[6-(2,5-dimethoxyphenyl)-5-imidazo[2,1- b ]thiazolylmethylene]-2 -indolinone, which showed even cardiotonic activity, are potential coanthracyclinic agents.


European Journal of Medicinal Chemistry | 2000

4-Aminopyridine derivatives with antiamnesic activity

Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Claudio Pietra; Gino Villetti

Acetylcholine (Ach) enhancement, useful in the treatment of Alzheimers disease (AD), may be obtained by means of ion channel modulators such as 4-aminopyridine (4-AP). 4-AP is also the central ring of tacrine, the first drug approved for the treatment of AD. The synthesis and pharmacological activity of three 4-AP derivatives, prepared with the aim of improving their antiamnesic activity, is here described. In two of these compounds 4-AP is connected to 4-aminobutyric acid (GABA), whereas in the third it is connected to 2-indolinone, i.e., the skeleton of linopirdine, another Ach enhancing agent. The new compounds showed potent antiamnesic activity in comparison with piracetam.


European Journal of Medicinal Chemistry | 1999

6-Thienyl and 6-phenylimidazo[2,1-b]thiazoles as inhibitors of mitochondrial NADH dehydrogenase

Aldo Andreani; Mirella Rambaldi; Alberto Leoni; Rita Morigi; Alessandra Locatelli; Gianluca Giorgi; Giorgio Lenaz; Anna Ghelli; Mauro Degli Esposti

Starting from the potent inhibitory effect of the previously described 2-methyl-6-(2-thienyl)imidazo[2,1-b]thiazole on mitochondrial complex I, we prepared a series of derivatives in order to study the effect of a different substitution at the positions 2, 5 and 6. The replacement of the thienyl group at position 6 with a phenyl group does not modify the biological behaviour of the lead compound, whereas the shift of the methyl group from position 2 to position 5 yields a compound devoid of inhibitory effects. In both the 6-thienyl and 6-phenyl series, the lengthening of the chain at position 2 has provided useful information to outline the structural determinants of the ubiquinone antagonist action in imidazothiazole derivatives.


European Journal of Medicinal Chemistry | 1998

Synthesis and potential coanthracyclinic activity of pyridylmethylene and indolylmethylene lactams

Aldo Andreani; Alessandra Locatelli; Alberto Leoni; Rita Morigi; M Chiericozzi; Alessandra Fraccari; I. Galatulas; Gaetano Salvatore

The synthesis of pyridylmethylene lactams and indolylmethylene-2-indolinones is reported. These compounds were tested for their cytotoxic and positive inotropic activity. The presence of both the effects (coanthracyclinic activity) was confirmed in some of the indolylmethylene-2-indolinones.


Anti-cancer Drug Design | 2001

Synthesis and antitumor activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones.

Aldo Andreani; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Gianluca Giorgi; Laura Salvini; Garaliene


Drug Research | 2011

Synthesis and Antisecretory Activity of 6-Substituted 5-Cyanomethylimidazo[2,1-b]-thiazoles and 2,6-Dimethyl-5-hydroxymethylimidazo[2,1-b][1,3,4]thiadiazole

Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Wolfgang Simon; Joerg Senn‐Bilfinger


Anti-cancer Drug Design | 2000

Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition.

Aldo Andreani; Andrea Cavalli; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Maurizio Recanatini; Matthieu Garnier; Laurent Meijer


Drug Research | 1998

In vivo cardiotonic activity of pyridylmethylene-2-indolinones

Aldo Andreani; Alessandra Locatelli; Rita Morigi; Alberto Leoni; Rosaria Bossa; M Chiericozzi; I. Galatulas


Collection of Czechoslovak Chemical Communications | 1999

Ring-Opened Analogs of Indomethacin Affecting Human Neutrophil Functions

Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Jean-Claude Gehret; Serena Traniello; Alessio Cariani; Susanna Spisani

Collaboration


Dive into the Rita Morigi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge